Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Charts To Watch: AMD, ARWR, CLVS, CRSP, INGN, INMD, NVTA

Published 11/20/2019, 12:32 AM
Updated 07/09/2023, 06:31 AM

1. Advanced Micro Devices, Inc. (AMD)

AMD was up 1.41, or 3.54%, to 41.29, with a high of 41.79, on 92.5 million shares on Tuesday, and broke through my target at 40. It’s headed up toward the 44-45 zone. My next target is 45. I am now thinking 48-49 as the target, which is even more likely. Let’s see if it gets a pullback. It has gone 14 points in the last week and it’s still running.

2. Arrowhead Pharmaceuticals, Inc. (ARWR)

ARWR is one of our swings that also has a very similar pattern, and a very sharp one that is accelerating. On Tuesday, it was up 2.33, or 4.84%, to 50.50, on 2 million shares. The high was 51.74, a multi-year high going back 12 years. Right now, my target has to be in the mid 70’s, but on a short-term basis I’m looking at the high 50’s.

3. Clovis Oncology , Inc. (CLVS)

CLVS had a big turnaround and continues to push on Tuesday, up another 73 cents, or 10.34%, to 7.79, with a high of 8.20, on 19 million shares. That’s very good volume. I’m now looking at 9 1/4 as the next target going forward.

5. Inogen, Inc. (INGN)

INGN is still sitting in the ascending bull wedge or coil, and popped 1.52, or 2.18%, to 71.18, reaching a high of 71.47, on 253,643 shares traded on Tuesday. If it takes out 73, look for it to run up to 77, 85, and 93.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

4. CRISPR Therapeutics AG (CRSP)

CRSP exploded 9.93, or 17%, to 68.46, with a high of 74.00, on a hefty 5.6 million shares on Tuesday. I haven’t seen that since it went public on a positive up day. That’s a really good sign, but it is up against resistance from the 2018 high, so it may stall in this range since it’s already been up there. It went from 35 straight up to 74. Big move of 40 points.

6. InMode Ltd. (INMD)

INMD hit the top of the channel on Monday, then had an inside day on Tuesday, but still jumped 3.61, or 6.9%, to 55.84, with a high of 56.75, on 1.5 million shares, and is still holding up. Momentum could carry INMD into the mid 60’s.

7. Invitae Corporation (NVTA)

NVTA a swing of ours, after popping and wedging, broke out, I gave you a swing on it, it backed off and filled the mini-gap on Monday, and on Tuesday, it came on again, jumping 1.14, or 6.24%, to 19.40, with a high of 19.72, on 2.5 million shares. The next target is 22-23, and then something around 26-27.

Stocks on the long side

Advanced Micro Devices, Inc. (NASDAQ:AMD), Arrowhead Pharmaceuticals, Inc. (ARWR), Athenex, Inc. (ATNX), Axsome Therapeutics, Inc. (AXSM), Clovis Oncology, Inc. (CLVS), CRISPR Therapeutics AG (CRSP), Dicerna Pharmaceuticals, Inc. (DRNA), Inogen, Inc. (INGN), InMode Ltd. (INMD), Direxion Daily S&P Biotech Bull 3X ETF (LABU), Limelight Networks, Inc. (LLNW), Myovant Sciences Ltd. (MYOV), Invitae Corporation (NVTA), Puma Biotechnology, Inc. (PBYI), SmileDirectClub, Inc. (SDC), Tesla, Inc. (NASDAQ:TSLA), 58.com Inc. (WUBA), Weight Watchers International I (WW), and XBiotech Inc. (XBIT).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Watch video here...

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.